Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Newborns of Obese Mothers

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
El enlace se guarda en el portapapeles.
EstadoTerminado
Patrocinadores
Assistance Publique - Hôpitaux de Paris

Palabras clave

Abstracto

This was a prospective bi-centric study, exposed-unexposed. In an effort to better understand the potential independent effect of maternal obesity on fetal growth, investigators designed a prospective study, comparing fetal growth between normal weight (18.5 ≤ BMI < 25 kg/m2) or obese pregnant women (BMI ≥ 30 kg/m2), while maternal diabetes and hyperglycaemia was screened and treated throughout pregnancy.

Descripción

The study population concerned obese pregnant women (BMI ≥ 30 kg / m² before pregnancy) and their newborn and normal weight pregnant women (18.5 ≤IMC <25 kg/m²) and their newborn as control. Inclusion criteria were body mass index (BMI) ≥ 30 kg/m2 or 18.5 ≤ BMI < 25 kg/m2, 18 ≤ age ≤ 40 years, singleton pregnancy. Exclusion criteria were: 25 ≤ BMI <30 kg/m2, age < 18 or > 40 years, multiple pregnancy, first consultation after 18 WG, pregestational diabetes, obesity due to genetic disorder or secondary to intracranial tumor or radiotherapy, bariatric surgery, chronic diseases other than the obesity, inability to converse in French language. The matching criteria for controls were: age ± 5 years, primigravida or multigravida, duration of gestation ± 4 weeks.

The main objective of this project was to assess the independent effect of maternal obesity:

- on the weight and adipose tissue of newborn

- on the function of adipose tissue (production of leptin and adiponectin)

- on fetal growth factors (C-peptide, IGF-1)

- on carbohydrate metabolism of the newborn. Two maternities were involved in the study: Pitié Salpêtrière and Armand Trousseau, in Paris, France. This research was conducted over a 3 years period. The duration of participation of each woman corresponded to the duration of pregnancy care and duration of care for the newborn immediately after birth, usually the length of stay in the maternity.

The only differences compared to the usual care included:

- Additional oral glucose tolerance test at 32 weeks of gestation;

- Determination of fasting blood glucose during late pregnancy

- Maternal blood samples on arrival at the delivery room

- Drawing blood from the umbilical cord after section;

- Skinfold measurement of the newborn within 72 hours of life.

fechas

Verificado por última vez: 01/31/2016
Primero enviado: 02/09/2016
Inscripción estimada enviada: 02/09/2016
Publicado por primera vez: 02/11/2016
Última actualización enviada: 04/04/2016
Última actualización publicada: 04/05/2016
Fecha de inicio real del estudio: 06/30/2010
Fecha estimada de finalización primaria: 09/30/2013
Fecha estimada de finalización del estudio: 09/30/2013

Condición o enfermedad

Obesity

Intervención / tratamiento

Procedure: Obstetric management

Fase

-

Grupos de brazos

BrazoIntervención / tratamiento
Experimental: Obese group
Active Comparator: Normal Weight group

Criterio de elegibilidad

Edades elegibles para estudiar 18 Years A 18 Years
Sexos elegibles para estudiarAll
Acepta voluntarios saludablessi
Criterios

Inclusion Criteria:

1. - BMI ≥30 kg / m² or between 18.50 and 24.99 kg / m².

2. - Pregnant woman coming to the centre before 18 weeks of gestation.

3. - Age ≥ 18 and ≤ 40 years

4. - Single Pregnancy

5. - No constitutional or progressive disease other than obesity: inflammatory disease, epilepsy, pathology psychiatric, tumor...

6. - Informed written consent.

Exclusion Criteria:

1. - Pregnant woman coming to the center after 18 weeks of gestation, BMI <18.5 kg / m² or between 25 and 29.99 Kg / m².

2. - Age <18 or> 40 years

3. - Multiple pregnancy

4. - Presence of a constitutional disease or progressive disease other than obesity.

5. - Patients who underwent obesity surgery type "bypass" or gastroplasty

6. - Obesity secondary to genetic disorder, intracranial lesions or pituitary radiotherapy

7. - not stabilized endocrine pathology.

8. - pregestational diabetes

9. - No affiliation to a social security scheme

Salir

Medidas de resultado primarias

1. ponderal index measured by a balance [at birth]

2. skinfold's measure measured by a special clamp [at birth]

3. birthweight [at birth]

Únete a nuestra
página de facebook

La base de datos de hierbas medicinales más completa respaldada por la ciencia

  • Funciona en 55 idiomas
  • Curas a base de hierbas respaldadas por la ciencia
  • Reconocimiento de hierbas por imagen
  • Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
  • Leer publicaciones científicas relacionadas con su búsqueda
  • Buscar hierbas medicinales por sus efectos.
  • Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.

Google Play badgeApp Store badge